(Reuters) -The U.S. Food and Drug Administration is probing the death of a patient who developed harmful antibodies after taking Takeda Pharmaceuticals' blood disorder therapy, the health regulator said on Friday.
The pediatric patient died about 10 months after starting Takeda's drug Adzynma as a preventive therapy, the agency said.
The child had congenital thrombotic thrombocytopenic purpura (cTTP), an inherited condition that causes blood clots in small vessels and can lead to organ damage.
The FDA said the child developed antibodies that blocked the activity of ADAMTS13, an enzyme critical for blood clotting.
Takeda did not immediately respond to Reuters request for comment.
Adzynma, approved in 2023 as the first therapy for cTTP, replaces the ADAMTS13 protein to help prevent dangerous blood clots.
The agency added it has received multiple postmarketing reports of patients developing neutralizing antibodies to ADAMTS13 after treatment with Adzynma.
(Reporting by Kamal Choudhury in Bengaluru; Editing by Vijay Kishore)
latest_posts
- 1
Closets for Your Room: Plan and Utility Features - 2Reveal Less popular Authentic Realities You Didn't Learn in School
- 3As Western heat wave ends, scientists try to make sense of its length and intensity
- 4Artemis 2 astronauts see Earth in the rear-view mirror | Space photo of the day for April 3, 2026
- 521 Things You Ought to Never Share with Your Childless Companion
- Hundreds are quarantined in South Carolina as measles spreads in 2 US outbreaks
- European nations criticise Israel’s death penalty plans
- Airport wait times won't return to normal until Congress reaches a deal to pay TSA. Here's why they still can't come to an agreement.
- Giude to Best Web based Learning Stage
- Figure out How to Store Your Gold Ventures: A Thorough Aide safely
- 'No Kings' protests live updates: More than 8 million turned out across all 50 states, organizers say
- More than 800 flights canceled as FAA cuts traffic at 40 major airports. Here's what to know.
- Coalition led by Iraqi PM al-Sudani wins parliamentary elections
- April’s full pink moon will rise in the night sky this week
